Ovarian Cancer: Translating Novel Pathways into Therapies
The Penn State Gynecologic Malignancies Group (GMG) is hosted its second Symposium focused on Ovarian Cancer on World Ovarian Cancer Day May 8, 2019. Our mission is to provide the audience of researchers, clinician scientists, health care workers, and patients with an overview of current advancements in the field of ovarian cancer research and translational medicine that promise new therapeutic avenues for the disease.
Location: University Conference Center – Penn State College of Medicine, Hershey PA, 17033. Directions.
Date & Time: May 8, 2019, 8am-1pm.
To join via zoom: https://psu.zoom.us/j/4010157111
Registration: Click here to Register. Lunch and coffee breaks are included, but require registration.
Confirmed Speakers:
Dr. Dineo Khabele, M.D., Professor of Obstetrics & Gynecology and Cancer Biology, Vice Chair for Research OBGYN, Director, Division of Gynecologic Oncology, The University of Kansas: “Expanding PARP Inhibitor Efficacy in Ovarian Cancer with Epigenetic Drugs”
Dr. June Y. Hou, M.D., Assistant Professor of Obstetrics & Gynecology, Director of Precision Medicine Initiate and Hereditary Breast and Ovarian Cancer Program, Columbia University: “Insights into the molecular building blocks of ovarian cancer: Exploiting new opportunities and strategies”
Dr. Katherine Aird, Ph.D., Assistant Professor of Cellular and Molecular Physiology, Penn State College of Medicine: “Exploiting metabolic pathways to sensitize ovarian cancers to PARP inhibitors”
Dr. George-Lucian Moldovan, Ph.D., Associate Professor of Biochemistry and Molecular Biology, Penn State College of Medicine: “Novel mechanisms regulating the response of BRCA-mutant tumors to genotoxic chemotherapy”
Symposium Chair: Nadine Hempel, Ph.D. & Rebecca Phaeton, M.D.
The meeting concludes with lunch and an Interactive Molecular Tumor Board Session: Plenary Speakers and the Audience discuss how to decide the best possible treatment options for patients in the context of novel molecular tumor markers and genetic testing. Hosted by Joshua Warrick M.D. and Joshua Kesterson M.D., Penn State College of Medicine.
For detailed Program information click here.
Posters: Poster sessions will be held during the coffee breaks. Please indicate if you intent to present a poster when you register for this event or send an email to Nadine Hempel (nhempel@psu.edu). We encourage all participants to bring posters highlighting some of their current research. These do not need to be ovarian cancer focused. We hope that the poster session will help to facilitate networking, research discussions and development of novel ideas that may be applied to Gynecologic Malignancies research in future. (Posters can be from previous conferences/meetings.)
For further information, please contact Nadine Hempel, PhD (nhempel@psu.edu) or Rebecca Phaeton, MD (rphaeton@pennstatehealth.psu.edu).
Support is generously provided by the Sue Alexander Tressler Memorial Research Fund, the Departments of Obstetrics & Gynecology and Pharmacology, the Penn State Center for Women’s Health Research, and the Penn State Cancer Institute.